Results 221 to 230 of about 19,854,960 (401)
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai+4 more
wiley +1 more source
Mechanism of Cardiac Troponin C Calcium Sensitivity Modulation by Small Molecules Illuminated by Umbrella Sampling Simulations. [PDF]
Bowman JD, Coldren WH, Lindert S.
europepmc +1 more source
Amino acid sequences of the two major isoforms of troponin C from crayfish
Tetsuo Kobayashi+3 more
openalex +1 more source
Neuronal Nitric-oxide Synthase Interaction with Calmodulin-Troponin C Chimeras [PDF]
Ratan Gachhui+7 more
openalex +1 more source
The emerging role of Nrf2 in heart failure: From cardioprotection to therapeutic approaches
Nrf2 signalling is impaired in heart failure, contributing to oxidative stress, mitochondrial dysfunction, and ferroptosis, which drive neurohormonal activation, inflammation, and ischaemia‐reperfusion injury. This loss of Nrf2 activity exacerbates hypertension, diabetic cardiomyopathy, and cardiotoxicity, accelerating progression to overt heart ...
Emiliano Fiori+9 more
wiley +1 more source
Differential expression of troponin C genes during tongue myogenesis [PDF]
Theodore I. Prigozy+3 more
openalex +1 more source
Distinct troponin C isoform requirements in cardiac and skeletal muscle
Vanessa M Sogah+5 more
semanticscholar +1 more source
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra+25 more
wiley +1 more source